News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Entertainment

Marvel announces ‘Guardians of Infinity’ comic

17-overlay13

"The Guardians of the Galaxy" adventures will continue in this new comic book, which ties in with the blockbuster film.

in Music

Want to buy Pink Floyd’s flying pig? Too late

pigs

Algie the flying pig is no longer up for sale -- going back to the band instead.

in Music

Dolly Parton teases new TV movie

21-overlay14

They hadn't even started shooting the movie, but Dolly Parton had no trouble selling "Coat of Many Colors" to critics. The film, set to air Dec. 10 on NBC, is inspired by Parton's childhood.